https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=AGENUS_INCAGENUS INC - Revizia istoricului2026-05-10T22:11:50ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=AGENUS_INC&diff=405211&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei AGENUS INC listata cu simbolul US.AGEN ==Descriere companie== Agenus Inc. (Agenus) (http://agenusbio.com/) is a clinical-stage immuno-oncology (I-O) company. It has a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer. Its I-O assets include antibody-based therapeutics, monospecific and bispecific antibodies, cell therapy, neoantigen cancer vaccines (individualized and off-the shelf) pla...2024-09-18T13:35:55Z<p>Pagină nouă: Pagina dedicata companiei AGENUS INC listata cu simbolul US.AGEN ==Descriere companie== Agenus Inc. (Agenus) (http://agenusbio.com/) is a clinical-stage immuno-oncology (I-O) company. It has a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer. Its I-O assets include antibody-based therapeutics, monospecific and bispecific antibodies, cell therapy, neoantigen cancer vaccines (individualized and off-the shelf) pla...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei AGENUS INC listata cu simbolul US.AGEN<br />
<br />
==Descriere companie==<br />
Agenus Inc. (Agenus) (http://agenusbio.com/) is a clinical-stage immuno-oncology (I-O) company. It has a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer. Its I-O assets include antibody-based therapeutics, monospecific and bispecific antibodies, cell therapy, neoantigen cancer vaccines (individualized and off-the shelf) platforms and adjuvants. Its anti-PD-1 antibody and first-generation and next generation anti-CTLA-4 antagonists are in clinical development. Its pipeline of pre-clinical assets, which include AGEN1777, an anti-TIGIT bispecific antibody and AGEN1327, an anti-TIGIT monospecific antibody. Its neoantigen vaccine platforms include its heat shock protein (HSP) based Prophage vaccine candidates and its synthetic, neoantigen vaccine candidates, AutoSynVax (ASV) and PhosphoSynVax (PSV). Its neoantigen vaccine platforms include individualized ASV and off-the-shelf PSV, which target antigens expressed across patients and tumors.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.AGEN" /><br />
<br />
==Ultimele stiri despre AGENUS INC (US.AGEN)==<br />
<dynamicpagelist><br />
category=US.AGEN<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.AGEN]][[Categorie:Stiri despre companii]]</div>Admin